InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Browse the complete record of transactions filed by Harford Simon N.R., Chief Financial Officer. Director active across 1 companies, notably Albireo Pharma, INC.. In total, 12 disclosures have been published. Total volume traded: €40k. The latest transaction was filed on 22 April 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
€3,130103 shares@ €30.38697.8% of flow
Common Stock
SEC:0001209191-22-025525:0·
€3,15496 shares@ €32.8597.8% of flow
Common Stock
SEC:0001209191-22-023974:0·
€9,127416 shares@ €21.939122.6% of flow
Common Stock
SEC:0001209191-22-004807:0·
€9,127416 shares@ €21.939153.6% of flow
Common Stock
SEC:0001209191-22-004807·
021,600 shares0
Common Stock
SEC:0001209191-22-004063·
021,600 shares0
Common Stock
SEC:0001209191-22-004063:0·
€2,542111 shares@ €22.899814.9% of flow
Common Stock
SEC:0001209191-22-002923·
€2,542111 shares@ €22.89986.3% of flow
Common Stock
SEC:0001209191-22-002923:0·
€2,43493 shares@ €26.16814.3% of flow
Common Stock
SEC:0001209191-21-060216·
€2,43493 shares@ €26.1686.0% of flow
Common Stock
SEC:0001209191-21-060216:0·
€2,91598 shares@ €29.7417.1% of flow
Common Stock
SEC:0001209191-21-046787·
€2,91598 shares@ €29.747.2% of flow
Common Stock
SEC:0001209191-21-046787:0·
12 of 12 declarations
About Harford Simon N.R.
Simon N.R. Harford is the Chief Financial Officer and Treasurer at ALBIREO PHARMA, INC. He oversees the company's financial operations, including budget management and forecasting. His role is crucial in ensuring the financial health and growth of Albireo Pharma.
